ENTX - CIK 0001638097
The table below shows Entera Bio Ltd.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.11M | $8.66M | $11.02M | $12.31M | $24.89M | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $0.00 | $126.00K | $0.00 | $246.00K | $183.00K | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $15.30M |
| $8.97M |
| $11.26M |
| $12.85M |
| $25.33M |
| - |
| Property, plant & equipment | $134.00K | $57.00K | $100.00K | $139.00K | $156.00K | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $15.99M | $9.39M | $11.77M | $13.13M | $25.99M | $10.26M |
| Accounts payable | $448.00K | $132.00K | $83.00K | $17.00K | $166.00K | - |
| Total current liabilities | $2.20M | $1.18M | $1.09M | $1.34M | $3.16M | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $2.89M | $1.31M | $1.38M | $1.37M | $3.42M | $3.60M |
| Retained earnings | -$125.37M | -$113.93M | -$104.39M | -$95.50M | -$82.43M | - |
| Total equity | $13.10M | $8.08M | $10.39M | $11.75M | $22.57M | - |